Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
Yunxing Shi(Sun Yat-sen University), Binkui Li(Sun Yat-sen University)
Cited by 40
Related Papers
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer
|Nature Communications|2023|81